Showing results (621-630 of 1,191) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|June 23, 2010
On assessing the presence of evaluation-time bias in progression-free survival in randomized trialsRichard Kay, Jane Wu, Janet WittesPharmaceutical Statistics|December 9, 2010
A guide to the design and analysis of small clinical studiesFarid Kianifard, M Zahur IslamPharmaceutical Statistics|September 28, 2010
An optimal adaptive design to address local regulations in global clinical trialsXiaolong Luo, Weichung Joe Shih, S Peter Ouyang, et al.Pharmaceutical Statistics|September 28, 2010
Assessing consistent treatment effect in a multi-regional clinical trial: a systematic reviewJoshua Chen, Hui Quan, Bruce Binkowitz, et al.Pharmaceutical Statistics|November 25, 2010
Assessing departure from dose linearity under a repeated measures incomplete block designBin Cheng, Shein-Chung ChowPharmaceutical Statistics|June 6, 2009
Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidanceHui Quan, Peng-Liang Zhao, Ji Zhang, et al.Pharmaceutical Statistics|September 1, 2009
Comparison of several imputation methods for missing baseline data in propensity scores analysis of binary outcomeBrenda J Crowe, Ilya A Lipkovich, Ouhong WangPharmaceutical Statistics|September 19, 2009
Increasing the sample size at interim for a two-sample experiment without Type I error inflationKeith Dunnigan, Dennis W KingPharmaceutical Statistics|June 2, 2020
Comparison of two treatments in the presence of competing risksJingjing Lyu, Jinbao Chen, Yawen Hou, et al.Pharmaceutical Statistics|September 8, 2021
Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADERJulie Kjaerulff Furberg, Søren Rasmussen, Per Kragh Andersen, et al.Pageof 120